FDA NDC Directory · JSON-LD · Markdown

Etoposide

NDC 0378-3266 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameetoposide
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA075635
Dosage form / routeCAPSULE · ORAL
Active ingredientsETOPOSIDE (50 mg/1)
Marketing started20011022
Package count1

External sources

Source: openFDA. Public-domain (CC0).